Survey on Hereditary Angioedema (HAE)

According to a recent survey, hereditary angioedema is a rare genetic disorder that affects approximately 1 in 50,000 people worldwide. It is characterized by recurrent episodes of swelling in the skin and mucous membranes, which can be painful and potentially life-threatening if they occur in the airways or digestive tract. The condition results from a deficiency or dysfunction of C1 inhibitor protein, which regulates immune system activity and prevents excess fluid from leaking out of blood vessels into surrounding tissues. Symptoms may first appear during childhood or adolescence and often worsen over time without proper treatment. There are currently several medications available to prevent attacks or treat acute symptoms, including plasma-derived C1 inhibitor replacement therapy, bradykinin receptor antagonists, and kallikrein inhibitors. However, many patients still struggle to obtain prompt diagnosis and access to these treatments due to limited awareness among healthcare providers and high costs associated with their use. Ongoing research efforts are focused on improving diagnostic accuracy, developing new therapies with longer duration of action or better tolerability profiles than existing options, and exploring potential links between hereditary angioedema and other inflammatory conditions such as autoimmune disease or cancer.

To take this Survey and to participate in more such Surveys

Recommended Surveys

Survey on Psoriatic arthritis

Survey on skin rashes

Survey on Pink eye

Survey on Use of AI in Health and Medicine

Survey on Lung cancer

CI-AKI awareness survey

Survey on hepatitis of unknown etiology in children

Invasive fungal infections

Survey on COVID-related depression

Survey on hormone therapy

Survey on treating MRSA infections

Booster vaccine survey

Survey on rheumatoid arthritis

Survey on ascites

Metoprolol Survey

Survey on Childhood trauma

Diabetes survey

Survey on the Use of AI in Cancer Treatment

Survey on serious skin infections

Survey on H3N2 flu

Participate in Surveys and WIN POINTS!